ICIs in SCLC: Pipeline Landscape
06 checkpoint molecules are being targeted by 28 inhibitors in 104 trials (~70% are in combination with other agents)
Inner Circle: Immune Checkpoint Molecules being investigated in SCLC
Middle Circle: 'Monotherapy' means the inhibitor against the corresponding target is being studied alone
Outer Circle: Represents phase and the number of trials in the format Phase X; N
Special thanks to Ms. Rashmi and Ms. Uhanjali for the help with the clinical trial screening and coding. Also, many thanks to Mr. Aditya Jha for help with the Sunburst chart.